Drug recall · October 1, 2025
Dextroamphetamine Saccharate recall
Why: Failed Impurities/Degradation Specifications:
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 10 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-030-01
- Lots / codes
lot#: GPC250159A, Exp Date: 06-22-2027
- Quantity
- 11,895 bottles
- Company
- Granules Pharmaceuticals Inc., Chantilly, VA
- Distribution
- Distributed Nationwide in the USA
- Initiated
- August 28, 2025 · Voluntary: Firm initiated
- Classified
- September 24, 2025
- Reported
- October 1, 2025
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.